Small Molecules Research, Development & Manufacturing Services

Cambrex specializes in a wide array of technologies and services aimed at supporting the pharmaceutical development lifecycle, particularly in the areas of drug substance and drug product manufacturing. Their expertise encompasses the development and manufacturing of active pharmaceutical ingredients (APIs) across various phases, from early clinical trials to commercial launch. Cambrex employs innovative approaches such as continuous flow manufacturing, which enhances efficiency and scalability in drug production. They also focus on high-potency APIs and complex synthetic molecules, utilizing advanced techniques like biocatalysis and crystallization process development to meet the unique challenges posed by modern pharmaceuticals.

In addition to their manufacturing capabilities, Cambrex emphasizes the importance of customized analytical services and technology transfer processes to ensure regulatory compliance and quality throughout the drug development journey. Their scientist-led teams work collaboratively with clients to tailor solutions that address specific project needs, thereby facilitating a seamless transition from development to commercialization. Cambrex's commitment to innovation and quality is further reflected in their state-of-the-art facilities and a robust portfolio of services designed to support both traditional and complex drug formulations.

United States

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services. 

With over 40 years of experience and a growing team of over 2,000 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing. 

Cambrex

Company Details